LNC
JAZZ icon

Lincoln National Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lincoln National Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,122
Closed -$321K – 507
2018
Q1 		$321K Sell
2,122
-2,122
-50% -$311K 0.01% 358
2017
Q4 		$571K Buy
4,244
+2,122
+100% +$294K 0.02% 339
2017
Q3 		$311K Sell
2,122
-150
-7% -$22.7K 0.01% 307
2017
Q2 		$353K Sell
2,272
-16
-0.7% -$2.45K 0.02% 241
2017
Q1 		$332K Buy
2,288
+400
+21% +$52.1K 0.02% 242
2016
Q4 		$206K Buy
+1,888
New +$210K 0.01% 281

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Lincoln National Corp's JAZZ Position: Q2 2018 in Review

Lincoln National Corp sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2018, closing a stake of 2,122 shares — an estimated $321K sold.

Lincoln National Corp first reported a position in JAZZ in Q4 2016 and held it in 6 quarters. The position peaked at $571K in Q4 2017. 376 funds tracked by Wall St. Rank hold JAZZ as of Q2 2018.

  • Lincoln National Corp reported no remaining Jazz Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Lincoln National Corp sold 2,122 Jazz Pharmaceuticals shares in Q2 2018, an estimated $321K.
  • Lincoln National Corp first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 6 quarters.
  • Lincoln National Corp's Jazz Pharmaceuticals position peaked at $571K in Q4 2017.
  • 376 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2018.

Based on Lincoln National Corp's 13F filing for Q2 2018, filed 8 Aug 2018.